- Synonyms40-O-(2-Hydroxyethyl-13Cd4)rapamycin; 42-O-(2-Hydroxy)ethyl-13Cd4 Rapamycin; Afinitor-13Cd4; Certican-13Cd4; RAD-13Cd4; RAD 001-13Cd4; SDZ-RAD-13Cd4; XIENCE V-13Cd4
- Description
40-O-(2-Hydroxyethyl-13Cd4)rapamycin; 42-O-(2-Hydroxy)ethyl-13Cd4 Rapamycin; Afinitor-13Cd4; Certican-13Cd4; RAD-13Cd4; RAD 001-13Cd4; SDZ-RAD-13Cd4; XIENCE V-13Cd4
Everolimus-13C2-d4 is a fully characterized chemical compound used as a reference standard of API Everolimus. The standard offered is compliant with regulatory guidelines. Everolimus-13C2-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1661009-29-5